Document ID: chunk:federal_register_of_legislation:F2021L00943:clause:3_93647
Version: federal_register_of_legislation:F2021L00943
Segment Type: clause
Provision Reference: sch 3 cl 93647
Character Range: 24010–26158

93647                                                                                                          Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patient's suitability for the second or subsequent dose of a COVID-19 vaccine if all of the following apply:      28.20
                                                                                                                 (a) one or both of the following is undertaken, where clinically relevant:
                                                                                                                    (i) a short patient history;
                                                                                                                   (ii) limited examination and management;
                                                                                                                 (b) the service is bulk-billed;
                                                                                                                 (c) the service is provided at, or from, a practice location in:
                                                                                                                 (i)  a Modified Monash 2 area; or
                                                                                                                 (ii) a Modified Monash 3 area; or
                                                                                                                 (iii) a Modified Monash 4 area; or
                                                                                                                 (iv) a Modified Monash 5 area; or
                                                                                                                 (v) a Modified Monash 6 area; or
                                                                                                                 (vi) a Modified Monash 7 area
Subgroup 4— After-Hours Assessing Patient Suitability for the Second or Subsequent Dose of a COVID-19 Vaccine